Means, Responders, and Meaning
New Approaches to Prevention of Thrombosis in the Antiphospholipid Syndrome
Systemic and Local Regulation of Articular Cartilage Metabolism
Infections and Anti–Tumor Necrosis Factor α Therapy
Raynaud's Phenomenon and the Role of Capillaroscopy
Comparison of Rheumatoid Arthritis Clinical Trial Outcome Measures
Prognostic Factors in a Large Cohort of Patients with Early Undifferentiated Inflammatory Arthritis After Application of a Structured Management Protocol
Association Between Etanercept Use and Employment Outcomes Among Patients With Rheumatoid Arthritis
Coffee Consumption and Risk of Rheumatoid Arthritis
Inflammation and Bone Resorption as Independent Factors of Accelerated Arterial Wall Thickening in Patients With Rheumatoid Arthritis
Tumor Necrosis Factor α, Its Soluble Receptor I, and −308 Gene Promoter Polymorphism in Patients With Rheumatoid Arthritis With or Without Amyloidosis
Use of Positron Emission Tomography With Methyl-11C-Choline and 2-18F-Fluoro-2-Deoxy-D-Glucose in Comparison With Magnetic Resonance Imaging for the Assessment of Inflammatory Proliferation of Synovium
Turnover of Type II Collagen and Aggrecan in Cartilage Matrix at the Onset of Inflammatory Arthritis in Humans
Rheumatoid Arthritis Synovial Fluid Macrophages Express Decreased Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand R2 and Increased Decoy Receptor Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand R3
Comparing the Efficacy of Cyclooxygenase 2–Specific Inhibitors in Treating Osteoarthritis
Risk Factors for Progression of Lumbar Spine Disc Degeneration
Evidence for a Key Role of Leptin in Osteoarthritis
The release of crosslinked peptides from type II collagen Into Human Synovial Fluid Is Increased Soon After Joint Injury and in Osteoarthritis
Nitrite-Mediated Protection Against Hypochlorous Acid–Induced Chondrocyte Toxicity
Cyclic Tensile Stretch Loaded on Bovine Chondrocytes Causes Depolymerization of Hyaluronan
Risk Factors for Coronary Heart Disease in Women With Systemic Lupus Erythematosus
Coronary Artery Angiography in Systemic Lupus Erythematosus Patients With Abnormal Myocardial Perfusion Scintigraphy
Triplets With Systemic Lupus Erythematosus
Extrasalivary Lymphoma Development in Sjögren's Syndrome
Cellular Basis of Ectopic Germinal Center Formation and Autoantibody Production in the Target Organ of Patients With Sjögren's Syndrome
The −174G Allele of the Interleukin-6 Gene Confers Susceptibility to Systemic Arthritis in Children
Safety of Hydroxychloroquine in Pregnant Patients With Connective Tissue Diseases
Reduction of Job Loss in Persons With Rheumatic Diseases Receiving Vocational Rehabilitation
Endothelial Nitric Oxide Synthase Gene Polymorphisms in Giant Cell Arteritis
Bone Density Threshold and Other Predictors of Vertebral Fracture in Patients Receiving Oral Glucocorticoid Therapy
Recombinant Human Tumor Necrosis Factor Receptor (Etanercept) for Treating Ankylosing Spondylitis
The Influence of Fetal Loss on the Presence of Fetal Cell Microchimerism
A Novel Polymorphism in the Fcγ Receptor IIB (CD32B) Transmembrane Region Alters Receptor Signaling
Generation and Characterization of Lymphostat-B, a Human Monoclonal Antibody That Antagonizes the Bioactivities of B Lymphocyte Stimulator
Articular, Monoclonal γ3 Heavy-Chain Deposition Disease
Inhibition of the Thrombogenic and Inflammatory Properties of Antiphospholipid Antibodies by Fluvastatin in an in Vivo Animal Model
Acceleration of the Onset of Collagen-Induced Arthritis by a Deficiency of Platelet Endothelial Cell Adhesion Molecule 1
Expression and localization of opioid receptors in muscle satellite cells
Humoral immunity to Ro52 is not associated with the Ro52 9571 C/T polymorphism in Australian patients with primary Sjögren's syndrome
Examination of the possible role of biologically relevant genes around FBN1 in systemic sclerosis in the Choctaw population
Cytomegalovirus infection and antiphospholipid syndrome in humans
The A/T mutation in exon 2 of the DNASE1 gene is not present in Tunisian patients with systemic lupus erythematosus or in healthy subjects
Long-term followup needed to define role of infliximab in treatment of renal amyloidosis
Treatment of renal amyloidosis in rheumatoid arthritis requires further investigation
Treatment of renal amyloidosis in rheumatoid arthritis requires further investigation
Erratum
ACR ANNOUNCEMENTS